Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01972347
Brief Title: Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma

First Submitted : June 17, 2013
First Submitted that Met QC Criteria : October 24, 2013
First Posted : October 30, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : March 12, 2019
Last Update Posted : March 14, 2019